This presentation covers paediatric onset in Multiple Sclerosis (MS).
MS, a chronic inflammatory autoimmune disease of the CNS is commonly diagnosed in young adults but can also affect children.
Clinical onset before the age of 18 (16) years has an incidence of between 0.5 and 1.66 /100 000 children. Between 3 and 10% of MS >16 y and < 1% under 10 years of age.
BIOGRAPHY
MELINDA MAGYARI
Melinda Magyari is the director of The Danish Multiple Sclerosis Registry (link: www.dmsr.dk/) and a consultant neurologist at the Danish Multiple Sclerosis Center (COI). Her major research area is in multiple sclerosis and other inflammatory disorders of the central nervous system with a special interest in the changing epidemiology and gender differences. Using nationwide population-based data sources her research addresses questions on comorbidities, reproductive issues, risk factors and socioeconomic consequences in multiple sclerosis. She is involved in pharmacoepidemiological studies investigating the effectiveness and long-term safety of disease modifying therapies.
Media
